With this extension, NTT DATA will continue to sell Datatrak eClinical and Enterprise Transfer services within the Japanese market.
Moreover, Datatrak has decided to extend its product’s capabilities in Post Marketing Studies and is adapting related functionalities in response to demands from the Japanese clinical trials market.
Datatrak chairman of the board and CEO Laurence Birch said NTT DATA continues to be a successful strategic partner, and they are excited to assist in the delivery of Datatrak eClinical as they expand into the Japanese PMS market.